DE68912331D1 - Erniedrigung der zellvermehrung und steigerung der killerzellenaktivität. - Google Patents

Erniedrigung der zellvermehrung und steigerung der killerzellenaktivität.

Info

Publication number
DE68912331D1
DE68912331D1 DE89908068T DE68912331T DE68912331D1 DE 68912331 D1 DE68912331 D1 DE 68912331D1 DE 89908068 T DE89908068 T DE 89908068T DE 68912331 T DE68912331 T DE 68912331T DE 68912331 D1 DE68912331 D1 DE 68912331D1
Authority
DE
Germany
Prior art keywords
reduction
increase
cell
reproduction
killer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89908068T
Other languages
English (en)
Other versions
DE68912331T2 (de
Inventor
Abulkalam M Shamsuddin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22796898&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE68912331(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE68912331D1 publication Critical patent/DE68912331D1/de
Publication of DE68912331T2 publication Critical patent/DE68912331T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
DE68912331T 1988-06-30 1989-06-30 Erniedrigung der zellvermehrung und steigerung der killerzellenaktivität. Expired - Fee Related DE68912331T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/213,889 US5082833A (en) 1988-06-30 1988-06-30 Reduction of cell proliferation and enhancement of nk-cell activity
PCT/US1989/002874 WO1990000057A1 (en) 1988-06-30 1989-06-30 Reduction of cell proliferation and enhancement of nk-cell activity

Publications (2)

Publication Number Publication Date
DE68912331D1 true DE68912331D1 (de) 1994-02-24
DE68912331T2 DE68912331T2 (de) 1994-05-19

Family

ID=22796898

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68912331T Expired - Fee Related DE68912331T2 (de) 1988-06-30 1989-06-30 Erniedrigung der zellvermehrung und steigerung der killerzellenaktivität.

Country Status (5)

Country Link
US (1) US5082833A (de)
EP (1) EP0422109B1 (de)
JP (1) JP3188897B2 (de)
DE (1) DE68912331T2 (de)
WO (1) WO1990000057A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260287A (en) * 1992-05-11 1993-11-09 Board Of Regents, The University Of Texas System Polyphosphorylated organic compounds: compositions useful in protecting biological tissues
SE501793C2 (sv) * 1993-10-08 1995-05-15 Perstorp Ab Användning av inositoltrisfosfat för beredning av läkemedel
SE502989C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av läkemedel
SE502574C2 (sv) * 1994-01-25 1995-11-13 Perstorp Ab En farmaceutisk komposition med förbättrad biotillgänglighet hos inositolfosfat
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
US5523090A (en) * 1995-02-24 1996-06-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin treatment composition
EP0728468A3 (de) 1995-02-26 2000-07-19 Unilever Plc Kosmetische Mittel zur Behandlung von Juckreiz
US5552148A (en) * 1995-06-07 1996-09-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly with inositol phosphates
US5614511A (en) * 1996-03-11 1997-03-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for treating itchy skin
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
AU4944500A (en) * 1999-06-29 2001-01-31 Robert H. Jacobs A method for optimizing immune activity in the treatment of auto-immune diseases and chronic immune conditions
WO2001080848A1 (fr) * 2000-04-25 2001-11-01 Hokko Chemical Industry Co., Ltd. Compositions destinees a inhiber la proliferation du virus d'immunodeficience humaine et methode d'inhibition de la proliferation de ce virus
US7084126B1 (en) * 2000-05-01 2006-08-01 Healthpartners Research Foundation Methods and compositions for enhancing cellular function through protection of tissue components
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
WO2003092700A1 (en) 2002-04-29 2003-11-13 Gmp Oxycell, Inc. Inositol pyrophosphates, and methods of use thereof
ES2232302B1 (es) * 2003-11-07 2006-08-01 Universitat De Les Illes Balears Myo-inositol hexafosfato para uso topico.
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20060258626A1 (en) * 2004-07-06 2006-11-16 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US7745423B2 (en) * 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
US7618615B2 (en) 2004-08-13 2009-11-17 Healthpartners Research Foundation Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
US9216161B2 (en) 2004-08-13 2015-12-22 Healthpartners Research Foundation Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity
DK1863495T3 (en) * 2005-03-18 2015-04-20 Normoxys Inc CALCIUM AND SODIUM SALT OF MYO-INOSITOL 1.6: 2,3: 4,5 TRIPYROPHOSPHATE FOR CANCER TREATMENT
US20070212449A1 (en) * 2006-03-02 2007-09-13 Shamsuddin Abulkalam M Reduction of the titratable acidity and the prevention of tooth and other bone degeneration
US20070293458A1 (en) * 2006-06-16 2007-12-20 Ip-6 Research Inc. Prevention of nuclear, solar, and other radiation-induced tissue damage
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof
US20090214474A1 (en) * 2006-11-01 2009-08-27 Barbara Brooke Jennings Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
JP2010526068A (ja) * 2007-05-01 2010-07-29 ノームオクシス インコーポレイテッド エリスロポエチン補完または置換
US9707274B2 (en) 2007-06-08 2017-07-18 Healthpartners Research & Education Methods for preventing and treating post-traumatic stress disorder (PTSD)
JP5496897B2 (ja) * 2007-10-04 2014-05-21 ザイモジェネティクス， インコーポレイテッド Ｂ７ファミリーメンバーのｚＢ７Ｈ６ならびに関連する組成物および方法
CA2783740C (en) 2009-12-09 2020-03-10 Institut National De La Sante Et De La Recherche Medicale Monoclonal antibodies that bind b7h6 and uses thereof
US10279012B2 (en) 2013-03-11 2019-05-07 Healthpartners Research & Education Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin
US10314911B2 (en) 2014-04-08 2019-06-11 Healthpartners Research & Education Methods for protecting and treating traumatic brain injury, concussion and brain inflammation with intranasal insulin
WO2020045653A1 (ja) * 2018-08-30 2020-03-05 国立大学法人 熊本大学 フィチン酸エステル誘導体

Also Published As

Publication number Publication date
DE68912331T2 (de) 1994-05-19
JP3188897B2 (ja) 2001-07-16
EP0422109A1 (de) 1991-04-17
EP0422109A4 (en) 1991-06-12
EP0422109B1 (de) 1994-01-12
WO1990000057A1 (en) 1990-01-11
US5082833A (en) 1992-01-21
JPH05503914A (ja) 1993-06-24

Similar Documents

Publication Publication Date Title
DE68912331T2 (de) Erniedrigung der zellvermehrung und steigerung der killerzellenaktivität.
DE68926347T2 (de) Speicherstruktur und verwendung
DE3869184D1 (de) Festelektrolyt-brennstoffzelle und zusammenbau.
DE68920223D1 (de) Enzymelektroden und ihre Herstellung.
DE3876839T2 (de) Stuhl- und wagenkombination.
DE3579880D1 (de) Plattentraeger und stopfen.
DE3781263D1 (de) Peptid-derivate und deren verwendung in der therapie.
EP0456640A4 (de) Genetisch erzeugte endothelzellen und deren verwendung.
DE58904478D1 (de) Strahlungsempfindliche gemische und deren verwendung.
KR900701296A (ko) T세포 헬퍼 활성을 가진 펩티드
DE3778757D1 (de) Lagerungs- und verteilungsmittel.
ES534446A0 (es) Perfeccionamientos en fonocardiografos y electrocardiografos
DE3851904D1 (de) Sperrung von verteilten Dateien und Aufzeichnungen.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
DE3679764D1 (de) Zaepfchen und grundlage dafuer.
IT8022851A0 (it) Glicosaminoglicani modificati dotati di attivita' antilipemica e privi di attivita' anticoagulante.
IT8747783A0 (it) Fiammenghi e domenighetti fiammenghi - via quattro fontane, 31 roma
DE3677826D1 (de) Antiulceroese mittel und quassinoide.
NO894399D0 (no) Optisk aktive benzoksasiner og benzotiaziner.
IT1200102B (it) Preparazioni farmaceutiche comprendenti chetotifere ed una xartina ad azione antiasmatica in combinazione fissa
DE3852141D1 (de) Platteneinheit und Kassettenanordnung.
DE3673111D1 (de) Wurmtoetende chinolinylacylhydrazone und mittel.
DE3673403D1 (de) Saeugetier-protein mit immunomodulatorischer und traechtigkeitfoerdernder aktivitaet.
ATA280289A (de) Kühl- und frischhaltezelle
ES1001859Y (es) Porta-precios y mensajes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee